SEC 13F Intelligence

Vestcor Inc / VRTX

Vestcor Inc’s Vertex Pharmaceuticals Inc Position

Does Vestcor Inc own Vertex Pharmaceuticals Inc (VRTX)? Yes34.0K shares worth $15M (+0.42% of its 13F portfolio) as of Q1 2026, down from 36.7K shares the prior filed quarter.

Position Value
$15M
Q1 2026
Shares
34.0K
% of Portfolio
+0.42%
Quarters Held
26
currently held

Position History VRTX

Reported value by quarter
Q4 ’19: $976,000Q4 ’19Q1 ’20: $1MQ2 ’20: $7MQ3 ’20: $7MQ4 ’20: $9MQ4 ’20Q1 ’21: $10MQ2 ’21: $9MQ3 ’21: $1MQ4 ’21: $1MQ4 ’21Q1 ’22: $19MQ2 ’22: $21MQ3 ’22: $23MQ4 ’22: $24MQ4 ’22Q1 ’23: $24MQ2 ’23: $27MQ3 ’23: $25MQ4 ’23: $29MQ4 ’23Q1 ’24: $27MQ2 ’24: $30MQ3 ’24: $30MQ4 ’24: $21MQ4 ’24Q1 ’25: $16MQ2 ’25: $14MQ3 ’25: $14MQ4 ’25: $17MQ4 ’25Q1 ’26: $15Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202634.0K$15M+0.42%
Q4 202536.7K$17M+0.47%
Q3 202535.3K$14M+0.41%
Q2 202531.5K$14M+0.42%
Q1 202532.1K$16M+0.52%
Q4 202452.6K$21M+0.70%
Q3 202465.3K$30M+0.96%
Q2 202464.0K$30M+1.01%
Q1 202464.8K$27M+0.93%
Q4 202370.9K$29M+0.98%
Q3 202373.0K$25M+0.93%
Q2 202376.2K$27M+0.98%
Q1 202377.7K$24M+0.89%
Q4 202284.2K$24M+0.89%
Q3 202279.7K$23M+0.87%
Q2 202274.7K$21M+0.78%
Q1 202271.7K$19M+0.64%
Q4 20216.2K$1M+0.05%
Q3 20217.1K$1M+0.05%
Q2 202146.0K$9M+0.31%
Q1 202146.6K$10M+0.38%
Q4 202038.8K$9M+0.38%
Q3 202027.0K$7M+0.34%
Q2 202022.5K$7M+0.34%
Q1 20205.5K$1M+0.07%
Q4 20194.5K$976,000+0.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vestcor Inc’s full portfolio or all institutional holders of VRTX.